PFE News 28.70 08/01/2014 05:29:59 Pfizer Inc (PFE)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Pfizer Inc (PFE) 28.70 $PFE

'Mad Money' Lightning Round: Be Patient With Zynga
at The Street - 29 mins ago
Cramer like Energy Transfer Partner's yield, would buy Kinder Morgan Energy Partners but thinks Pfizer is problematic.

Jim Cramer's 'Mad Money' Recap: This, Too, Shall Pass
at The Street - Thu Jul 31, 7:24PM CDT
Even Cramer says there's not much to like in the markets just yet because the best stocks still aren't down low enough to be attractive.

Baxter International Falls as Pfizer Acquires Vaccines - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 31, 5:06PM CDT
The fall in Baxter International (BAX) shares is justified as the company has revealed that it expects the deal to mar its fourth quarter earnings and lower 2015 earnings by roughly 15 cents per share

Most active New York Stock Exchange-traded stocks
AP - Thu Jul 31, 5:04PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:

Final Glance: Pharmaceuticals companies
AP - Thu Jul 31, 5:04PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were down at the close of trading:

Midday Glance: Pharmaceuticals companies
AP - Thu Jul 31, 12:34PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are down at 1 p.m.:

Next Support Level for Pfizer (PFE) is $28.77
Comtex SmarTrend(R) - Thu Jul 31, 11:41AM CDT
Pfizer (NYSE FE) has opened bearishly below the pivot of $29.28 today and has reached the first level of support at $29.01. Analysts will be watching for a cross of the next downside pivot targets of $28.77 and $28.26.

3 Eye-Catching Health Care Stocks this Earnings Season - Earnings ESP
Zacks Equity Research - Zacks Investment Research - Thu Jul 31, 10:44AM CDT
These stocks are well positioned in today’s market environment.

Tax Inversion: Boon for Firms & Investors, Bane for U.S. Treasury - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 31, 10:41AM CDT
The U.S. Treasury may lose $19.5 billion over the next decade due to tax inversion.

Early Glance: Pharmaceuticals companies
AP - Thu Jul 31, 9:37AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:

Dividends, Upcoming Conference Schedules, Quarterly Earnings Releases, and Acquisitions - Research Reports on Wells Fargo, JPMorgan, Citigroup, Regions and Pfizer
PR Newswire - Thu Jul 31, 8:10AM CDT
Today, Analysts Review released its research reports regarding Wells Fargo & Co. (NYSE: WFC), JPMorgan Chase & Co. (NYSE: JPM), Citigroup Inc. (NYSE: C), Regions Financial Corp. (NYSE: RF) and Pfizer Inc. (NYSE: PFE). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5304-100free.

Pfizer to buy portfolio of marketed vaccines for USD635m
M2 - Thu Jul 31, 6:04AM CDT
Science company Pfizer (NYSE FE) reported on Wednesday the launch of a definitive agreement to acquire a portfolio of marketed vaccines, NeisVac-C and FSME-IMMUN/TicoVac, from Baxter International for USD635m.


Asian markets drift after US Fed stays course
By KAY JOHNSON - AP - Wed Jul 30, 11:37PM CDT
MUMBAI, India (AP) — Asian stock markets were uninspired by an upbeat report on the U.S. economy, with most drifting lower Thursday after the U.S. Federal Reserve said it would make further cuts to its monetary stimulus as expected.

Pharma ETFs in Focus on String of Earnings Beat - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Wed Jul 30, 1:00PM CDT
Though the major industry players beat on earnings, performances have been mixed, pushing down pharma ETFs.

Pfizer buying two Baxter vaccines for $635M
AP - Wed Jul 30, 11:39AM CDT
NEW YORK (AP) — Pfizer will spend $635 million on two vaccines owned by Baxter International that are sold in a number of European countries and other locations outside of the U.S.

Dow Today: Pfizer (PFE) Lower
at The Street - Wed Jul 30, 11:00AM CDT
Holding back the Dow today is Pfizer (NYSE: PFE ), which is lagging the broader Dow index with a 32-cent decline (-1.1%) bringing the stock to $29.14.

Amgen Pleases the Street -- but Will Layoffs Keep Critics at Bay?
at The Street - Wed Jul 30, 10:05AM CDT
Amgen's reallocation of resources is not quieting critics who want a bigger restructuring.

Baxter Announces Divestiture of Commercial Vaccines Business to Pfizer
M2 - Wed Jul 30, 9:58AM CDT
Baxter International Inc. (NYSE:BAX) today announced that it has entered into a definitive agreement to sell its two commercially marketed vaccines and related production facilities to Pfizer Inc. for a total cash consideration of $635 million, subject to certain adjustments.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lennar Faces Legal Heat Over Alleged Misleading Statements

Updated Category News Views 78

Rumbling Legal Drama with Lennar Corporation Every trader knows the uneasy feeling when a stock you're eyeing takes a surprising nosedive on some legal muck coming out of the woodwork. Well, it's Lennar Corporation's turn in the spotlight for all the wrong reasons. They're getting slapped with a class action lawsuit by investors claiming the company pulled a fast one...

Continue Reading
Sabre Unveils AI Travel Tech: A Bold New Frontier

Updated Category News Views 49

Sabre's Game-Changing AI Travel Integration I'm no stranger to bold moves in the travel industry, but what Sabre's rolling out tomorrow might just be the biggest leap we've seen in a while. They're unleashing what's called the first global travel plug-in within Grok Bot, marking a significant shake-up in the travel tech sphere. Too many tech upgrades in this business...

Continue Reading
Gold Tumbles: Kinross Faces Class Action Lawsuit

Updated Category News Views 139

Digging Deep into Kinross's Legal Fallout Well, here's a doozy for those investing in the precious metal market. Kinross Gold Corporation (NYSE: KGC) finds itself knee-deep in legal muck. Investors who bought into the Canadian gold miner's promises might be scrambling, as a class action lawsuit has just been lobbed their way. The culprit? A hefty drop-off in their...

Continue Reading
Palatin's Game-Changer: MC4R Agonist Hits the Stage

Updated Category News Views 83

Breaking New Ground in Obesity Treatment Palatin Technologies is stepping into the spotlight with some heavy ammunition in the fight against obesity. The company has just unveiled impressive preclinical data about their next-generation melanocortin-4 receptor (MC4R) agonists at the ObesityWeek® 2026 conference. This isn’t just your run-of-the-mill corporate...

Continue Reading
LinkedIn Shines: Brands Face Social Media Slump

Updated Category News Views 77

LinkedIn: The Unsung Hero in Social Platforms In a world where social media seems to be as unpredictable as the stock market, LinkedIn is surprisingly holding the line. According to Vista Social's 2027 report, LinkedIn proudly boasts the highest median engagement rate among brand pages at 5.8%. Now, in the wild west of social media, where reach is getting tougher to snag,...

Continue Reading
WHP Global's Japan Move: A Major Toy Market Play

Updated Category News Views 93

New Horizons for Toys"R"Us in Japan Well, folks, look who's back in the toy game with a vengeance! WHP Global is shaking hands with Pan Pacific International Holdings (PPIH) to breathe new life into Toys"R"Us across Japan. Now PPIH isn’t just any player. We're talking about Japan's fourth-largest retailer, helming giants like Don Quijote and aiming to crown itself as...

Continue Reading
Ranger and Smith Unveil Tea-Infused Chocolate Bar

Updated Category News Views 63

Fresh Collaborations in Portland's Culinary Scene Ah, the sweet crossover in Portland's food scene is once again in the spotlight with a new entry that's sure to titillate taste buds. Ranger Chocolate Co. and Steven Smith Teamaker are at it again, rolling out a delectable creation that merges the poetic elegance of tea with the indulgent richness of chocolate. Welcome,...

Continue Reading
Dawson Struggles With Q3 Losses Despite Growth Prospects

Updated Category News Views 110

Profit and loss dance around like a jittery stock, and Dawson Geophysical is feeling the heat this third quarter. Numbers are in, and we’re seeing a net loss of $5.2 million, translating to $0.17 per share—ouch. Not to mention a negative Adjusted EBITDA of $2 million. Compared to last year's hopes, that's a serious belly flop. Revenue Down, Hopes Up In a fetching...

Continue Reading
Crocs to Present at Key Industry Conferences

Updated Category News Views 69

Crocs Set to Step into the Spotlight Alright, if there's one thing about Crocs, Inc. (NASDAQ: CROX) that never fails to surprise, it's how they constantly keep everyone on their toes. The iconic casual footwear brand with its whimsical, love-it-or-hate-it reputation is strapping in for not one but two hefty conferences. They've circled November 19 and December 1, 2026, on...

Continue Reading
China's APEC Summit: A Catalyst for Business Growth?

Updated Category News Views 135

A Shift Toward Regional Stability China's position as this year's APEC rotating chair presents both opportunity and challenge as economies grapple with trade barriers and technological upheaval. The 33rd APEC Economic Leaders' Meeting in Shenzhen is intended to navigate these turbulent waters, setting the stage for a more stable regional environment. APEC's Role in...

Continue Reading

Top 5 Most Recently Viewed Articles

Air Products Secures $140 Million in NASA Liquid Hydrogen Contracts

Updated Category News Views 85

Air Products Receives Significant NASA Contracts Air Products, a leading supplier in the industrial gases market, recently announced an impressive contract award from NASA valued at over $140 million. This contract aims at supplying liquid hydrogen for various NASA facilities, most notably the renowned Kennedy Space Center and other significant sites where vital space...

Continue Reading
Navigating Market Realities: A Look Ahead for Investors

Updated Category News Views 158

The Uncomfortable Truth About Market Valuations Many investors may feel uneasy hearing this, but it’s essential to face the real data regarding market potential. After analyzing the last 40 years of market information from various developed economies, including movements in China, the reality might deter those banking on robust returns in the forthcoming decade. There's...

Continue Reading
Sodexo Unveils Its Universal Registration Document for 2025

Updated Category News Views 367

Introduction to Sodexo's Fiscal 2025 Document Sodexo has made significant strides in enhancing transparency and providing essential information through its recently filed Fiscal 2025 Universal Registration Document (URD). This document, which is now accessible to investors and stakeholders, showcases the company's ongoing commitment to accountability and sustainability....

Continue Reading
Paratus Energy's Q4 2025 Results: Key Indicators to Analyze

Updated Category News Views 197

Paratus Energy Services Ltd. (PLSV) is about to drop its unaudited interim Q4 2025 financial results on February 27, 2026. But here’s the kicker—traders are left with scant intel leading into this call, and that can rattle markets. First off, let’s talk about the earnings whispers. The usual playbook includes scouring through EPS projections and revenue figures, but...

Continue Reading
Keefe Adjusts Rating for Bank of N.T. Butterfield Amid Challenges

Updated Category News Views 72

Keefe Downgrades the Bank of N.T. Butterfield Stock Rating Recently, Keefe, Bruyette & Woods revised its recommendation for Bank of N.T. Butterfield (NYSE: NTB) stock, shifting the rating from Outperform to Market Perform. The price target has also been adjusted from $44 to $41. This reflects the bank's forecast of significant net interest income (NII) challenges...

Continue Reading